Matthew J. Carter

Tremona Road
Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

The natural history of osteogenesis imperfecta: a systematic review.

The natural history of osteogenesis imperfecta: a systematic review.

Journal: Bone reports
Published: April 10, 2026

Bleeding and thrombosis in intestinal transplantation; data from 145 consecutive adult transplants.

Bleeding and thrombosis in intestinal transplantation; data from 145 consecutive adult transplants.

Journal: Research and practice in thrombosis and haemostasis
Published: May 12, 2025

Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura.

Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura.

Journal: Blood
Published: May 05, 2025

The E3 ubiquitin ligase HUWE1 is required for KRAS-induced lung cancer.

The E3 ubiquitin ligase HUWE1 is required for KRAS-induced lung cancer.

Journal: Cell death & disease
Published: March 20, 2025

Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trial.

Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trial.

Journal: BMJ open
Published: December 26, 2024

The ETS-family transcription factor PU.1 is a critical regulator of the inhibitory Fcγ receptor IIB expression in humans.

The ETS-family transcription factor PU.1 is a critical regulator of the inhibitory Fcγ receptor IIB expression in humans.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 04, 2024

Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib.

Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib.

Journal: Blood
Published: August 25, 2023

Case report: Successful treatment of refractory immune thrombocytopenia in chronic lymphocytic leukaemia with venetoclax monotherapy.

Case report: Successful treatment of refractory immune thrombocytopenia in chronic lymphocytic leukaemia with venetoclax monotherapy.

Journal: Frontiers in oncology
Published: July 17, 2023

KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity.

KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 02, 2021

Enhancing the inpatient ward learning environment: A practical guide.

Enhancing the inpatient ward learning environment: A practical guide.

Journal: The clinical teacher
Published: October 20, 2021

HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy.

HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy.

Journal: Journal of experimental & clinical cancer research : CR
Published: October 04, 2021

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment.

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment.

Journal: Blood advances
Published: March 17, 2021
Showing 1-12 of 28

Last Updated: 09/26/2026